New Resources for Designing and Running Master Protocols Webinar Slides Posted on October 13, 2020February 6, 2025 by Hannah Faulkner New Resources for Designing and Running Master Protocols Webinar Slides
Investigators from Multiple U.S. Organizations Collaborate on First Embedded Pragmatic Clinical Trial Using National Health Plans’ Data Posted on September 1, 2020February 5, 2025 by Hannah Faulkner Investigators from Multiple U.S. Organizations Collaborate on First Embedded Pragmatic Clinical Trial Using National Health Plans’ Data
More than a Box to Check: Research Sponsor and Investigator Perspectives on Making GCP Training Relevant Posted on August 13, 2020February 6, 2025 by Hannah Faulkner More than a Box to Check: Research Sponsor and Investigator Perspectives on Making GCP Training Relevant
Master Protocol Design & Implementation: Charting Multi-Stakeholder Pathways to Success Posted on June 25, 2020February 6, 2025 by Hannah Faulkner Master Protocol Design & Implementation: Charting Multi-Stakeholder Pathways to Success
CTTI Novel Endpoints Interactive Selection Tool Posted on June 24, 2020February 21, 2025 by Hannah Faulkner CTTI Novel Endpoints Interactive Selection Tool
Appendix 1: Resources for Training and Learning Posted on June 8, 2020February 6, 2025 by Hannah Faulkner Appendix 1: Resources for Training and Learning
Table: Approaches for Safety Monitoring & Managing Safety Signals when using Digital Health Technologies for Data Capture Posted on June 7, 2020February 6, 2025 by Hannah Faulkner Table: Approaches for Safety Monitoring & Managing Safety Signals when using Digital Health Technologies for Data Capture
Table: Promoting & Protecting Data Integrity Posted on June 7, 2020February 6, 2025 by Hannah Faulkner Table: Promoting & Protecting Data Integrity
Table: CTTI Recommended Strategies for Optimizing Data Quality Posted on June 7, 2020February 6, 2025 by Hannah Faulkner Table: CTTI Recommended Strategies for Optimizing Data Quality
Continued investigator engagement: Reasons principal investigators conduct multiple FDA-regulated drug trials Posted on March 7, 2020February 6, 2025 by Hannah Faulkner Continued investigator engagement: Reasons principal investigators conduct multiple FDA-regulated drug trials
